二甲双胍在恶性肿瘤治疗中的研究进展
x
请在关注微信后,向客服人员索取文件
篇名: | 二甲双胍在恶性肿瘤治疗中的研究进展 |
TITLE: | Research progress on metformin in the treatment for malignant tumors |
摘要: | 近年来二甲双胍潜在的抗肿瘤效果在肿瘤治疗领域引起了广泛关注。本文综述了二甲双胍在恶性肿瘤治疗中的研究进展,发现其在消化系统恶性肿瘤(胆道癌、胃癌、食管癌、结直肠癌、胰腺癌、肝癌)、生殖系统恶性肿瘤(前列腺癌、卵巢癌、乳腺癌、宫颈癌)、非小细胞肺癌、肾细胞癌和黑色素瘤等治疗中显示出应用潜力。二甲双胍可抑制肿瘤细胞的增殖并延长患者的总生存期,其作用机制包括但不限于抑制线粒体复合物Ⅰ活性、激活腺苷一磷酸活化蛋白激酶/p53信号通路、阻滞细胞周期等。二甲双胍与化疗药物的联合使用显示出了减毒增效的潜力,其能增强胆道癌、卵巢癌和黑色素瘤细胞对化疗药物的敏感性,改善胃癌和结直肠癌细胞对化疗药物的耐药性,并减少乳腺癌患者在化疗过程中的毒性反应。二甲双胍还被用作免疫调节剂,应用于食管癌、结直肠癌、宫颈癌、非小细胞肺癌以及黑色素瘤患者的免疫治疗。 |
ABSTRACT: | In recent years, the potential anti-tumor effects of metformin have attracted widespread attention in the field of cancer treatment. This article summarizes the research progress of metformin in the treatment of malignant tumors,finding its potential application in the treatment of malignant tumors in the digestive system (biliary tract cancer,gastric cancer,esophagus cancer,colorectal cancer,pancreatic cancer,liver cancer) and reproductive system (prostate cancer,ovarian cancer,breast cancer, cervical cancer),non-small cell lung cancer,renal cell carcinoma,and melanoma. Metformin can inhibit the proliferation of tumor cells and extend the overall survival of patients. Its mechanisms of action include,but are not limited to,inhibiting the activity of mitochondrial complex Ⅰ,activating adenosine monophosphate-activated protein kinase/p53 signaling pathway,and blocking the cell cycle. Additionally,the combined use of metformin with chemotherapy drugs has shown potential for reducing toxicity and enhancing efficacy. It can enhance the sensitivity of biliary tract cancer,ovarian cancer,and melanoma cells to chemotherapy drugs, improve the drug resistance of gastric and colorectal cancer cells to chemotherapy,and reduce the toxic reactions of breast cancer patients during chemotherapy. Metformin is also used as an immunomodulator,applied in the immunotherapy of patients with esophagus cancer,colorectal cancer,cervical cancer,non-small cell lung cancer,and melanoma. |
期刊: | 2024年第35卷第15期 |
作者: | 段雪玉;廖彬彬;李蕾;张鼎才;陈瑞祥;刘晓波 |
AUTHORS: | DUAN Xueyu,LIAO Binbin,LI Lei,ZHANG Dingcai,CHEN Ruixiang,LIU Xiaobo |
关键字: | 二甲双胍;恶性肿瘤;作用机制;临床应用 |
KEYWORDS: | metformin; malignant tumors; mechanism of action; clinical application |
阅读数: | 56 次 |
本月下载数: | 0 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!